CTLA4 and neoplasm: We also investigated the role of signaling pathways in cancer cell proliferation, metastasis, and drug resistance, as well as the effectiveness of immune therapy including immune checkpoint pathways such as PD-1/PD-L1 and CTLA-4, and the activation of immune cells such as NK cells and tumor-associated macrophages in the immune microenvironment.